Symbol="OMER"
AssetType="Common Stock"
Name="Omeros Corporation"
Description="Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and markets protein and small molecule therapies, and orphan indications targeting inflammation, complement-mediated diseases, central nervous system (CNS) disorders, and system-related diseases. immunological. The company is headquartered in Seattle, Washington."
CIK="1285819"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="201 ELLIOTT AVENUE WEST, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="284613000"
EBITDA="-163196000"
PERatio="None"
PEGRatio="-0.17"
BookValue="0.874"
DividendPerShare="0"
DividendYield="0"
EPS="-2.9"
RevenuePerShareTTM="-0.479"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.221"
ReturnOnEquityTTM="-7.29"
RevenueTTM="-30004000"
GrossProfitTTM="-71397000"
DilutedEPSTTM="-2.9"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.149"
AnalystTargetPrice="15.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.934"
PriceToBookRatio="8.44"
EVToRevenue="8.26"
EVToEBITDA="-1.514"
Beta="0.985"
num_52WeekHigh="7.8"
num_52WeekLow="1.735"
num_50DayMovingAverage="5.79"
num_200DayMovingAverage="4.17"
SharesOutstanding="62829000"
DividendDate="None"
ExDividendDate="None"
symbol="OMER"
open="4.39"
high="4.54"
low="4.30"
price="4.35"
volume="286878.00"
latest_trading_day="2023-07-31"
previous_close="4.36"
change="-0.01"
change_percent="-0.2294%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="4"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="96"
Volume_recent_avg="590712"
Change_recent_avg="0.01"
Delta_recent_avg="0.43"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="96"
Aroon_momentum_negative="4"
image_negative_thumbnail_id_1="155"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0021.jpeg"
image_negative_thumbnail_id_2="1100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_neutral_thumbnail_id_1="532"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="995"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0157.jpeg"
image_positive_thumbnail_id_2="700"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
